These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15717959)

  • 21. Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment.
    Santana CA; Faber TL; Soler-Peter M; Sanyal R; Esteves FP; Ornelas M; Folks RD; Verdes L; Santana LF; Candell-Riera J; Garcia EV
    Nucl Med Commun; 2008 Nov; 29(11):970-81. PubMed ID: 18836375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term survival of patients with viable and nonviable aneurysms assessed by 99mTc-MIBI SPECT and 18F-FDG PET: a comparative study of medical and surgical treatment.
    Zhang X; Liu XJ; Hu S; Schindler TH; Tian Y; He ZX; Gao R; Wu Q; Wei H; Sayre JW; Schelbert HR
    J Nucl Med; 2008 Aug; 49(8):1288-98. PubMed ID: 18632821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?
    Bax JJ; Wijns W
    J Nucl Med; 1999 Nov; 40(11):1893-5. PubMed ID: 10565786
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of cardiac magnetic resonance imaging in the assessment of myocardial viability.
    Shan K; Constantine G; Sivananthan M; Flamm SD
    Circulation; 2004 Mar; 109(11):1328-34. PubMed ID: 15037539
    [No Abstract]   [Full Text] [Related]  

  • 25. Prediction of left ventricular functional recovery by dobutamine echocardiography, F-18 deoxyglucose or 99mTc sestamibi nuclear imaging in patients with chronic myocardial infarction.
    Lund GK; Freyhoff J; Schwaiger M; Lübeck M; Lund CH; Buchert R; Sheehan FH; Meinertz T; Nienaber CA
    Cardiology; 2002; 98(4):202-9. PubMed ID: 12566650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
    Baer FM; Voth E; Deutsch HJ; Schneider CA; Horst M; de Vivie ER; Schicha H; Erdmann E; Sechtem U
    J Am Coll Cardiol; 1996 Jul; 28(1):60-9. PubMed ID: 8752795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction.
    Schinkel AF; Bax JJ; Sozzi FB; Boersma E; Valkema R; Elhendy A; Roelandt JR; Poldermans D
    Heart; 2002 Aug; 88(2):125-30. PubMed ID: 12117829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis.
    Bax JJ; Schinkel AF; Boersma E; Elhendy A; Rizzello V; Maat A; Roelandt JR; van der Wall EE; Poldermans D
    Circulation; 2004 Sep; 110(11 Suppl 1):II18-22. PubMed ID: 15364832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial viability in chronic ischemic cardiomyopathy: similarities and discordance of different diagnostic approaches.
    Weissman G; Asch FM
    J Cardiovasc Transl Res; 2009 Mar; 2(1):24-9. PubMed ID: 20559966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of thallium scintigraphy and positron emission tomography.
    Niemeyer MG; Kuijper AF; Meeder JG; Cramer MJ; Cleophas AJ; van der Wall EE
    Angiology; 1997 Oct; 48(10):843-53. PubMed ID: 9342963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular magnetic resonance imaging for detection of myocardial viability in chronic ischemic left ventricular dysfunction.
    Glaveckaite S; Valeviciene N; Laucevicius A; Celutkiene J; Rudys A; Tamosiūnas A
    Medicina (Kaunas); 2009; 45(8):585-99. PubMed ID: 19773617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging techniques in nuclear cardiology for the assessment of myocardial viability.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Dierckx RA; Jager PL
    Int J Cardiovasc Imaging; 2006 Feb; 22(1):63-80. PubMed ID: 16372139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.
    D'Egidio G; Nichol G; Williams KA; Guo A; Garrard L; deKemp R; Ruddy TD; DaSilva J; Humen D; Gulenchyn KY; Freeman M; Racine N; Benard F; Hendry P; Beanlands RS;
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1060-8. PubMed ID: 19761983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical benefit of noninvasive viability studies of patients with severe ischemic left ventricular dysfunction.
    Soto JR; Beller GA
    Clin Cardiol; 2001 Jun; 24(6):428-34. PubMed ID: 11403503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myocardial viability assessment and perioperative cardiovascular evaluation using single photon emission tomography and positron emission tomography].
    Yoshinaga K
    Kyobu Geka; 2007 Jul; 60(8 Suppl):627-34. PubMed ID: 17763661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation between QT dispersion and myocardial viability in ischemic cardiomyopathy.
    Schinkel AF; Bountioukos M; Poldermans D; Elhendy A; Valkema R; Vourvouri EC; Biagini E; Rizzello V; Kertai MD; Krenning B; Krenning EP; Roelandt JR; Bax JJ
    Am J Cardiol; 2003 Sep; 92(6):712-5. PubMed ID: 12972115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of myocardial viability with dobutamine stress echocardiography in patients with ischemic left ventricular dysfunction.
    Yao SS; Chaudhry FA
    Echocardiography; 2005 Jan; 22(1):71-83. PubMed ID: 15660693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of functional recovery after revascularization in patients with chronic ischemic myocardial dysfunction: perfusable tissue index by positron emission tomography and contrast-enhanced MRI comparison study.
    Bondarenko O; Knaapen P; Beek AM; Boellaard R; Lammertsma AA; van Rossum AC
    Nucl Med Commun; 2011 Dec; 32(12):1169-73. PubMed ID: 22045477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of myocardial viability.
    Travin MI; Bergmann SR
    Semin Nucl Med; 2005 Jan; 35(1):2-16. PubMed ID: 15645391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dobutamine-induced contractile reserve in stunned, hibernating, and scarred myocardium in patients with ischemic cardiomyopathy.
    Schinkel AF; Bax JJ; van Domburg R; Elhendy A; Valkema R; Vourvouri EC; Sozzi FB; Roelandt JR; Poldermans D
    J Nucl Med; 2003 Feb; 44(2):127-33. PubMed ID: 12571199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.